Human Longevity EU: what actually helps
Human Longevity EU — In Europe, longevity isn’t only personal—it collides with access, queues, and solidarity.
Red line: US-centric wellness imports sold as universal truth.
Your postcode and reimbursement rules shape prevention more than any import stack.
Case note: A test is standard care in country A and out-of-pocket in country B. Same evidence, completely different feasibility.
Example: screening intervals and reimbursement change what’s ‘reasonable’—not only the podcast.
Access and queues are part of prevention
Screening programmes differ by country—‘standard’ is not global.
Anti-ageing marketing often ignores who can afford the ‘basics’ first.
System traps that bend prevention
Copy-pasting US supplement stacks without interaction checks.
Treating NHS/BARMER-style realities as optional footnotes.
Systems before podcast stacks
What ‘optimal’ means is often reimbursement and queues—not an influencer with US shipping.
If your country’s queue shapes your screening, start with access-aware sequencing and what we can’t universalise from US stacks.
If you need the adjacent lens for this topic: practical healthspan basics.